logo-loader
viewCello Health PLC

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too.

The group delivered net revenue of £54.5mln for the first six months of the year, which was up 6.8% on a year ago, with like-for-like constant currency net revenue up 4.5%.

Quick facts: Cello Health PLC

Price: 133.425 GBX

AIM:CLL
Market: AIM
Market Cap: £141.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Equals Group PLC raises £16mln for acquisitions

Top stories from the Proactive UK newsroom. E payments group Equals (LON:EQLS) is to raise £16mln though a placing and open offer to give it some firepower to make acquisitions and accelerate the development of its corporate product.  Healthcare marketing group Cello Health (LON:CLL)...

on 16/8/19

RNS

Total Voting Rights

1 week, 6 days ago

Holding(s) in Company

3 weeks, 3 days ago

Holding(s) in Company

on 14/11/19

Total Voting Rights

on 13/11/19

Total Voting Rights

on 7/10/19

Disposal

on 2/10/19

Interim Results

on 18/9/19

2 min read